459 related articles for article (PubMed ID: 3552201)
1. Association in the expression of Kirsten-ras oncogene and the major histocompatibility complex class I antigens in fibrosarcoma tumor cell variants exhibiting different metastatic capabilities.
Alon Y; Hammerling GJ; Segal S; Bar-Eli M
Cancer Res; 1987 May; 47(10):2553-7. PubMed ID: 3552201
[TBL] [Abstract][Full Text] [Related]
2. Resistance to NK and metastatic potential of fibrosarcoma cells is associated with products encoded by the H-2D region.
Rager-Zisman B; Aboud M; Gopas J; Har-Vardi I; Hämmerling GJ; Segal S
Semin Cancer Biol; 1991 Oct; 2(5):329-36. PubMed ID: 1773048
[TBL] [Abstract][Full Text] [Related]
3. Metastatic capacity of cloned T10 sarcoma cells that differ in H-2 expression: inverse relationship to their immunogenic potency.
Katzav S; Segal S; Feldman M
J Natl Cancer Inst; 1985 Aug; 75(2):307-18. PubMed ID: 3894752
[TBL] [Abstract][Full Text] [Related]
4. Immune response to progressor variants derived from transfection of an ultraviolet radiation-induced C3H mouse regressor tumor cell line with activated Harvey-ras oncogene.
Kaba DS; Pierceall WE; Price JE; Ananthaswamy HN
Cancer Res; 1990 Jun; 50(11):3159-66. PubMed ID: 2185882
[TBL] [Abstract][Full Text] [Related]
5. Major histocompatibility complex antigens in v-Ki-ras transformed cells: the different antigens are expressed and induced by interferons independently of one another and of the anti-viral state.
Morris AG
Immunology; 1990 Oct; 71(2):224-9. PubMed ID: 1699881
[TBL] [Abstract][Full Text] [Related]
6. Alterations in major histocompatibility complex phenotypes of mouse cloned T10 sarcoma cells: association with shifts from nonmetastatic to metastatic cells.
Katzav S; De Baetselier P; Tartakovsky B; Feldman M; Segal S
J Natl Cancer Inst; 1983 Aug; 71(2):317-24. PubMed ID: 6576189
[TBL] [Abstract][Full Text] [Related]
7. Differential expression of the H-2Dk MHC class-I antigen and tissue inhibitor of metalloproteinases in metastatic and nonmetastatic T-10 fibrosarcoma cells.
Har-Vardi I; Gopas J; Rager-Zisman B; Hammerling GJ; Segal S; Aboud M
Invasion Metastasis; 1992; 12(5-6):301-8. PubMed ID: 1298741
[TBL] [Abstract][Full Text] [Related]
8. H-2K double transfectants of tumor cells as antimetastatic cellular vaccines in heterozygous recipients. Implications for the T cell repertoire.
Mandelboim O; Feldman M; Eisenbach L
J Immunol; 1992 Jun; 148(11):3666-73. PubMed ID: 1588053
[TBL] [Abstract][Full Text] [Related]
9. Epidermal growth factor regulates protein kinase A activity in murine fibrosarcoma cells: differences between metastatic and nonmetastatic tumor cell variants.
Fishman D; Galitzki L; Priel E; Segal S
Cancer Res; 1997 Dec; 57(23):5410-5. PubMed ID: 9393768
[TBL] [Abstract][Full Text] [Related]
10. Expression of two H-2K genes, syngeneic and allogeneic, as a strategy for potentiating immune recognition of tumor cells.
Mandelboim O; Vadai E; Feldman M; Eisenbach L
Gene Ther; 1995 Dec; 2(10):757-65. PubMed ID: 8750016
[TBL] [Abstract][Full Text] [Related]
11. The immunobiology of metastatic processes: analysis of NK sensitivity and the metastatic potential of H-2 gene transfected fibrosarcoma cells.
Gopas J; Rager-Zisman B; Bar-Eli M; Har-Vardi I; Hammerling GJ; Segal S
Nat Immun Cell Growth Regul; 1988; 7(3):155-62. PubMed ID: 2845261
[TBL] [Abstract][Full Text] [Related]
12. MHC class I genes controlling the metastatic phenotype of tumor cells.
Feldman M; Eisenbach L
Semin Cancer Biol; 1991 Oct; 2(5):337-46. PubMed ID: 1773049
[TBL] [Abstract][Full Text] [Related]
13. Abolishment of metastasis formation by murine tumor cells transfected with "foreign" H-2K genes.
Gelber C; Plaksin D; Vadai E; Feldman M; Eisenbach L
Cancer Res; 1989 May; 49(9):2366-73. PubMed ID: 2784997
[TBL] [Abstract][Full Text] [Related]
14. The c-fos proto-oncogene in murine 3LL carcinoma clones controls the expression of MHC genes.
Kushtai G; Barzilay J; Feldman M; Eisenbach L
Oncogene; 1988 Feb; 2(2):119-27. PubMed ID: 2453011
[TBL] [Abstract][Full Text] [Related]
15. Tumor rejection mediated by transfection with allogeneic class I histocompatibility gene.
Hui KM; Sim T; Foo TT; Oei AA
J Immunol; 1989 Dec; 143(11):3835-43. PubMed ID: 2584720
[TBL] [Abstract][Full Text] [Related]
16. c-fos and c-jun overexpression in malignant cells reduces their tumorigenic and metastatic potential, and affects their MHC class I gene expression.
Yamit-Hezi A; Plaksin D; Eisenbach L
Oncogene; 1994 Apr; 9(4):1065-79. PubMed ID: 8134110
[TBL] [Abstract][Full Text] [Related]
17. H-2 antigens and tumour-associated transplantation antigens in clones derived from a methylcholanthrene-induced BALB/c tumour: their influence on the generation in vitro and in vivo of the specific anti-tumour immune response.
Pérez M; Garrido A; Algarra I; Caballero A; Delgado C; Collado MD; Fernández-Cruz E; Garrido F
Exp Clin Immunogenet; 1989; 6(3):204-18. PubMed ID: 2631798
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of melanoma-associated antigen expression and ecotropic retrovirus production in B16BL6 melanoma cells transfected with major histocompatibility complex class I genes.
Li M; Muller J; Xu F; Hearing VJ; Gorelik E
Cancer Res; 1996 Oct; 56(19):4464-74. PubMed ID: 8813142
[TBL] [Abstract][Full Text] [Related]
19. Functional role of platelets in experimental metastasis studied with cloned murine fibrosarcoma cell variants.
Mahalingam M; Ugen KE; Kao KJ; Klein PA
Cancer Res; 1988 Mar; 48(6):1460-4. PubMed ID: 3345518
[TBL] [Abstract][Full Text] [Related]
20. Suppression of the metastatic phenotype of a mouse skin carcinoma cell line independent of E-cadherin expression and correlated with reduced Ha-ras oncogene products.
Caulín C; López-Barcons L; Gonzáles-Garrigues M; Navarro P; Lozano E; Rodrigo I; Gamallo C; Cano A; Fabra A; Quintanilla M
Mol Carcinog; 1996 Feb; 15(2):104-14. PubMed ID: 8599577
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
